Integrated computational and experimental analysis explores FOLH1 expression patterns across cancers and nominates melatonin as a potential modulator in prostate cancer models
Rui Zhang, Junyu Zhou, Sihan Dong, Guoquan Liu, Xunbin Wei · 2026
Read Integrated computational and experimental analysis explores FOLH1 expression patterns across cancers and nominates melatonin as a potential modulator in prostate cancer models by Rui Zhang, Junyu Zhou, Sihan Dong, Guoquan Liu, Xunbin Wei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218620.txt.
Description
Rui Zhang and co-authors scan every cancer for one protein's footprint, then let an algorithm nominate a familiar hormone against it. FOLH1, better known as the prostate cancer beacon PSMA, turns up abnormally across twenty-seven cancer types, with immune fingerprints that vary by tumor. A deep learning screen of candidate drugs pointed at melatonin.
In dishes, melatonin suppressed FOLH1 in a dose-dependent way, slowed the cancer cells' invasion and migration, and in mice it restrained tumor growth at levels mimicking the body's nightly rhythm. The authors are careful: melatonin is an exploratory candidate needing mechanistic proof, and the study's real product may be the combined computational and experimental pipeline for finding such candidates.
Catalog record
| CREATOR | Rui Zhang, Junyu Zhou, Sihan Dong, Guoquan Liu, Xunbin Wei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 109 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |